{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T13:26:23Z","timestamp":1788960383377,"version":"build-2803163510"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100014489","name":"Johnson & Johnson Pharmaceutical Research & Development","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100014489","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Janssen"},{"DOI":"10.13039\/100004312","name":"Lilly","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"crossref"}]},{"name":"AstraZeneca"},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100008021","name":"Bristol Myers Squibb","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008021","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100011725","name":"Servier","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100011725","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1016\/j.biopsych.2010.01.015","type":"journal-article","created":{"date-parts":[[2010,3,16]],"date-time":"2010-03-16T08:33:25Z","timestamp":1268728405000},"page":"156-162","source":"Crossref","is-referenced-by-count":130,"title":["Risperidone Long-Acting Injectable Monotherapy in the Maintenance Treatment of Bipolar I Disorder"],"prefix":"10.1016","volume":"68","author":[{"given":"Jorge A.","family":"Quiroz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakshmi N.","family":"Yatham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph M.","family":"Palumbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Karcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"Kushner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Kusumakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopsych.2010.01.015_bib1","series-title":"Manic-Depressive Illness: Bipolar Disorders and Recurrent Depression","author":"Goodwin","year":"2007"},{"key":"10.1016\/j.biopsych.2010.01.015_bib2","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.neubiorev.2007.04.003","article-title":"Kindling and sensitization as models for affective episode recurrence, cyclicity, and tolerance phenomena","volume":"31","author":"Post","year":"2007","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.biopsych.2010.01.015_bib3","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0006-3223(03)00420-7","article-title":"Social and economic burden of mood disorders","volume":"54","author":"Simon","year":"2003","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2010.01.015_bib4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/00043764-200301000-00007","article-title":"The health and productivity cost burden of the \u201ctop 10\u201d physical and mental health conditions affecting six large US employers in 1999","volume":"45","author":"Goetzel","year":"2003","journal-title":"J Occup Environ Med"},{"key":"10.1016\/j.biopsych.2010.01.015_bib5","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.psc.2005.01.001","article-title":"Atypical antipsychotics for bipolar disorder","volume":"28","author":"Yatham","year":"2005","journal-title":"Psychiatr Clin North Am"},{"key":"10.1016\/j.biopsych.2010.01.015_bib6","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1471-244X-7-40","article-title":"Atypical antipsychotics in bipolar disorder: Systematic review of randomised trials","volume":"7","author":"Derry","year":"2007","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.biopsych.2010.01.015_bib7","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1399-5618.2006.00314.x","article-title":"Treatment adherence with antipsychotic medications in bipolar disorder","volume":"8","author":"Sajatovic","year":"2006","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.biopsych.2010.01.015_bib8","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1176\/appi.ps.55.3.264","article-title":"Enhancement of treatment adherence among patients with bipolar disorder","volume":"55","author":"Sajatovic","year":"2004","journal-title":"Psychiatr Serv"},{"key":"10.1016\/j.biopsych.2010.01.015_bib9","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2165\/00023210-200721060-00001","article-title":"Long-acting formulations of atypical antipsychotics: Time to reconsider when to introduce depot antipsychotics","volume":"21","author":"Chue","year":"2007","journal-title":"CNS Drugs"},{"issue":"suppl 5","key":"10.1016\/j.biopsych.2010.01.015_bib10","first-page":"15","article-title":"Risks versus benefits of different types of long-acting injectable antipsychotics","volume":"67","author":"McEvoy","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.biopsych.2010.01.015_bib11","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1600-0447.2007.01059.x","article-title":"A 6-month randomized open-label comparison of continuation of oral atypical antipsychotic therapy or switch to long acting injectable risperidone in patients with bipolar disorder","volume":"434","author":"Yatham","year":"2007","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"10.1016\/j.biopsych.2010.01.015_bib12","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.pnpbp.2007.04.017","article-title":"Usefulness of long-acting injectable risperidone during 12-month maintenance therapy of bipolar disorder","volume":"31","author":"Han","year":"2007","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2010.01.015_bib13","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/YIC.0b013e3282f2b4c5","article-title":"Depot risperidone in the outpatient management of bipolar disorder: A 2-year study of 10 patients","volume":"23","author":"Malempati","year":"2008","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.biopsych.2010.01.015_bib14","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1111\/j.1399-5618.2009.00761.x","article-title":"A randomized, double-blind, placebo-controlled study of maintenance treatment with adjunctive risperidone long-acting therapy in patients with bipolar I disorder who relapse frequently","volume":"11","author":"Macfadden","year":"2009","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.biopsych.2010.01.015_bib15","series-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"2000"},{"key":"10.1016\/j.biopsych.2010.01.015_bib16","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A rating scale for mania: Reliability, validity and sensitivity","volume":"133","author":"Young","year":"1978","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.biopsych.2010.01.015_bib17","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.biopsych.2010.01.015_bib18","first-page":"218","article-title":"ECDEU Assessment Manual for Psychopharmacology","author":"Guy","year":"1976"},{"key":"10.1016\/j.biopsych.2010.01.015_bib19","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/j.1399-5618.2008.00611.x","article-title":"Reporting outcomes in clinical trials for bipolar disorder: A commentary and suggestions for change","volume":"10","author":"Martinez-Aran","year":"2008","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.biopsych.2010.01.015_bib20","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2307\/2530245","article-title":"A multiple testing procedure for clinical trials","volume":"35","author":"O'Brien","year":"1979","journal-title":"Biometrics"},{"key":"10.1016\/j.biopsych.2010.01.015_bib21","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1002\/sim.4780091207","article-title":"Group sequential designs using a family of type I error probability spending functions","volume":"9","author":"Hwang","year":"1990","journal-title":"Stat Med"},{"issue":"suppl 2","key":"10.1016\/j.biopsych.2010.01.015_bib22","first-page":"92S","article-title":"Continuation and prophylactic treatment of bipolar disorder","volume":"42","author":"Sharma","year":"1997","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.biopsych.2010.01.015_bib23","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1192\/bjp.148.6.723","article-title":"Comparison of the prophylactic action of flupenthixol with placebo in lithium treated manic-depressive patients","volume":"148","author":"Esparon","year":"1986","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.biopsych.2010.01.015_bib24","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1176\/appi.ajp.163.2.247","article-title":"Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine","volume":"163","author":"Tohen","year":"2006","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2010.01.015_bib25","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.4088\/JCP.v68n1003","article-title":"Aripiprazole monotherapy for maintenance therapy in bipolar I disorder: A 100-week, double-blind study versus placebo","volume":"68","author":"Keck","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.biopsych.2010.01.015_bib27","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1176\/appi.ajp.161.2.217","article-title":"Long-term lithium therapy for bipolar disorder: Systematic review and meta-analysis of randomized controlled trials","volume":"161","author":"Geddes","year":"2004","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2010.01.015_bib28","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.biopsych.2004.09.022","article-title":"Mood state at study entry as predictor of the polarity of relapse in bipolar disorder","volume":"56","author":"Calabrese","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2010.01.015_bib29","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1176\/appi.ajp.160.6.1125","article-title":"Long-acting injectable risperidone: Efficacy and safety of the first long-acting atypical antipsychotic","volume":"160","author":"Kane","year":"2003","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2010.01.015_bib30","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.4088\/JCP.v64n1017","article-title":"Treatment of schizophrenia with long-acting injectable risperidone: A 12-month open-label trial of the first long-acting second-generation antipsychotic","volume":"64","author":"Fleischhacker","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.biopsych.2010.01.015_bib31","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.euroneuro.2004.07.003","article-title":"Comparative efficacy and safety of long-acting risperidone and risperidone oral tablets","volume":"15","author":"Chue","year":"2005","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.biopsych.2010.01.015_bib32","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.4088\/JCP.v67n0804","article-title":"A 1-year double-blind study of 2 doses of long-acting risperidone in stable patients with schizophrenia or schizoaffective disorder","volume":"67","author":"Simpson","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.biopsych.2010.01.015_bib34","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/1359786806071248","article-title":"Improving patient outcomes in schizophrenia: Achieving remission","volume":"20","author":"Nasrallah","year":"2006","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.biopsych.2010.01.015_bib35","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.eurpsy.2008.12.002","article-title":"Long-term outcomes in patients with schizophrenia treated with risperidone long-acting injection or oral antipsychotics in Spain: Results from the electronic Schizophrenia Treatment Adherence Registry (e-STAR)","volume":"24","author":"Olivares","year":"2009","journal-title":"Eur Psychiatry"}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322310000570?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322310000570?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T19:06:22Z","timestamp":1588791982000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006322310000570"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["S0006322310000570"],"URL":"https:\/\/doi.org\/10.1016\/j.biopsych.2010.01.015","relation":{},"ISSN":["0006-3223"],"issn-type":[{"value":"0006-3223","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]}}}